Fingerprint
Dive into the research topics of 'Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein
Rouslan Kotchetkov, David Susman, Divaya Bhutani, Kaspar Broch, Angela Dispenzieri, Francis K. Buadi
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations